Episode 2 - Potential Implications of Rescheduling with Igor Grant, MD

In this episode (Recorded in December 2024), Drs. Igor Grant and Jamie Corroon discuss the potential implications of rescheduling cannabis from a Schedule I to a Schedule III controlled substance. They explore the current scheduling system, the medicinal value of cannabis, the challenges researchers face under Schedule I, and how rescheduling could impact research and funding. They also emphasize the need for harmonization between state and federal laws to facilitate cannabis research.